Skip to main content
Caplight Logo









Geneus Technologies (Chengdu) Co., Ltd.

Geneus Technologies (Chengdu) Co., Ltd.

Private
ChengduHealthcare & Life Scienceshttps://geneus-tech.com

Last Round

Series B

Mar 3, 2025

Total Funding Raised

$31.53M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Geneus Technologies (Chengdu) Co., Ltd. operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series B round in March 2025.

Geneus Technologies (Chengdu) Co., Ltd. is a biotechnology company that develops and commercializes fourth-generation nanopore gene sequencers and related reagents for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Geneus Technologies (Chengdu) Co., Ltd. Comparables

Compare Geneus Technologies (Chengdu) Co., Ltd. with similar companies based on industry and business-model similarity.

Geneus Technologies (Chengdu) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qitan Tech
89%
Anxuyuan Biotechnology (Shenzhen) Co., Ltd.
87%
Ruhan Gene Tech
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Geneus Technologies (Chengdu) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMar 3, 2025
Series BMar 2, 2023
Series BSep 29, 2021
Series AJul 31, 2020
AngelJan 29, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Geneus Technologies (Chengdu) Co., Ltd. Investors

Notable investors and investment history

Geneus Technologies (Chengdu) Co., Ltd. investors
InvestorRounds
Wedo Venture PartnersSeries B, Series A
Co-Win VenturesAngel
健壹资本Series B
GF Xinde Investment ManagementSeries B
Shenzhen Dachen Caizhi Venture Capital ManagementSeries B, Series A
Grand Mount CapitalSeries B
华创资本Series B
Book a demo to see all 8 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 62% MoM, reaching 2.6K.

  • May 16, 2026

    Monthly visitors increased 52% month-over-month.

Book a demo to see all signals

For institutional investors. Book with your work email.

Geneus Technologies (Chengdu) Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Geneus Technologies (Chengdu) Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Geneus Technologies (Chengdu) Co., Ltd.'s valuation, stock price, and market status.

Is Geneus Technologies (Chengdu) Co., Ltd. a public or private company?

Geneus Technologies (Chengdu) Co., Ltd. is a private company.

What is the current stock price of Geneus Technologies (Chengdu) Co., Ltd.?

Geneus Technologies (Chengdu) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Geneus Technologies (Chengdu) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Geneus Technologies (Chengdu) Co., Ltd. worth (valuation)?

Valuation information for Geneus Technologies (Chengdu) Co., Ltd. is not publicly available.

Can I buy Geneus Technologies (Chengdu) Co., Ltd. stock?

Geneus Technologies (Chengdu) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Geneus Technologies (Chengdu) Co., Ltd.'s last funding round?

Geneus Technologies (Chengdu) Co., Ltd.'s most recent funding round was Series B on March 3, 2025.

Who are the main investors in Geneus Technologies (Chengdu) Co., Ltd.?

Key investors in Geneus Technologies (Chengdu) Co., Ltd. include Wedo Venture Partners, Co-Win Ventures, GF Xinde Investment Management, 华创资本.

Will Geneus Technologies (Chengdu) Co., Ltd. IPO soon?

No public IPO plans have been announced for Geneus Technologies (Chengdu) Co., Ltd..

How can I track Geneus Technologies (Chengdu) Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Geneus Technologies (Chengdu) Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersChengdu
Employee Range4
Year Founded2017
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?